BioWorld Asia

Jan. 3, 2007

European Drug Agency Predicts Another Bumper Year in 2007

BRUSSELS, Belgium - The London-based European Medicines Agency is expecting a high level of activity in 2007, and much of the work is likely to come from evaluation of new biotechnology medicine applications. (BioWorld International) Read More

On The Brink of Bankruptcy, GeneMedix Finds A Rescuer

New Breast Cancer Gene Moves Focus To Role of DNA Repair

Neuropharma Raises $41.7M For Alzheimer's Development

Cellectis Files IPO Prospectus On The Paris Stock Exchange

Protherics seeking $74.4 M And Expanded Product Line

SkyePharma Gets New Loan For Flutiform Development

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for June 12, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 9, 2026

3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

Skape Bio unlocks GPCR targets with de novo-designed miniproteins

BioWorld

Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...

Pre-disease plasma signature may help redefine lung cancer risk

BioWorld

Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...

New 5-HT2C receptor agonists reported in Hansoh patent

BioWorld Science

Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...